GB201609790D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB201609790D0
GB201609790D0 GBGB1609790.9A GB201609790A GB201609790D0 GB 201609790 D0 GB201609790 D0 GB 201609790D0 GB 201609790 A GB201609790 A GB 201609790A GB 201609790 D0 GB201609790 D0 GB 201609790D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1609790.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Small Pharma Ltd
Original Assignee
Small Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Small Pharma Ltd filed Critical Small Pharma Ltd
Priority to GBGB1609790.9A priority Critical patent/GB201609790D0/en
Publication of GB201609790D0 publication Critical patent/GB201609790D0/en
Priority to US16/306,226 priority patent/US20190380978A1/en
Priority to PCT/GB2017/051618 priority patent/WO2017208031A1/en
Priority to EP17728640.8A priority patent/EP3463323B1/en
Priority to EP21203394.8A priority patent/EP3970712A3/en
Ceased legal-status Critical Current

Links

GBGB1609790.9A 2016-06-03 2016-06-03 Therapeutic compounds Ceased GB201609790D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1609790.9A GB201609790D0 (en) 2016-06-03 2016-06-03 Therapeutic compounds
US16/306,226 US20190380978A1 (en) 2016-06-03 2017-06-05 Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof
PCT/GB2017/051618 WO2017208031A1 (en) 2016-06-03 2017-06-05 Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof
EP17728640.8A EP3463323B1 (en) 2016-06-03 2017-06-05 Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof
EP21203394.8A EP3970712A3 (en) 2016-06-03 2017-06-05 Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1609790.9A GB201609790D0 (en) 2016-06-03 2016-06-03 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB201609790D0 true GB201609790D0 (en) 2016-07-20

Family

ID=56508075

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1609790.9A Ceased GB201609790D0 (en) 2016-06-03 2016-06-03 Therapeutic compounds

Country Status (1)

Country Link
GB (1) GB201609790D0 (en)

Similar Documents

Publication Publication Date Title
HK1256383A1 (en) Therapeutic agents
GB201509893D0 (en) Therapeutic agents
GB201517263D0 (en) Therapeutic agents
GB201415569D0 (en) Therapeutic Compounds
GB201603104D0 (en) Therapeutic agents
HK1258727A1 (en) Therapeutic compounds
GB201609597D0 (en) Therapy
GB201716942D0 (en) Therapeutic compounds
GB201502412D0 (en) Therapeutic use
GB201608797D0 (en) Therapeutic use
GB201509885D0 (en) Therapeutic agents
GB201509888D0 (en) Therapeutic agents
GB201416273D0 (en) Therapeutic compounds
GB201617339D0 (en) Therapeutic compounds
GB201616839D0 (en) Therapeutic compounds
GB201513299D0 (en) Therapeutic agents
GB201617470D0 (en) Novel therapy
GB201600376D0 (en) Novel therapeutic agents
GB201521767D0 (en) Therapeutic agents
IL263821A (en) Therapeutic compounds
GB201517264D0 (en) Therapeutic agents
GB201712394D0 (en) Therapeutic compounds
GB201712393D0 (en) Therapeutic compounds
GB201712395D0 (en) Therapeutic compounds
GB201712392D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)